& Partners
European Federation of Biotechnology
Kappa Health


The seconde International Funding Forum will take place on:

27 & 28 September 2012 in Zurich.

Further information will be available from June 2011 on this website. Contact us here.

Your IFF-team

International Conference on Research Funding: 12 & 13 June 09, Zurich/Switzerland

As the financial crisis makes it increasingly difficult to get money for Research & Development, the upcoming "Funding Forum" event is more needed than ever. You will get valuable information how money for R&D still can be acquired from diverse resources. The Forum helps you to find the answer to the questions:

  • Where to get funds/grants for R&D?
  • How to acquire and how to deal with funds?

  • We are pleased to announce the 1st RTD Funding Forum Conference an information event and training / workshops involving public and private, regional and international funding providers.
    Preliminary Programme PDF-document

    The origin of funds
    Funds are essential for Science, Research and Technological Developement (RTD). About 75% of the RTD funds are provided by the industry. 25% are coming from public resources, which allow more independent research.

    Funders expect results
    Money providers from both resources expect results – new knowledge, excellent young researchers/careers, novel methods and improved products which meet the need of the citizens – and therewith an economic impact at long term. A multitude of funding institutions are ready to feed researchers at all stages of their career with fellowships or financial contributions for projects (more and more often jointly with companies).

    Overview of funds is important
    However, it is a real challenge to get an overview. For a stable cash flow for a research team, an R&D intensive company or the planning of a competitive career an overview is crucial. The Funding Forum for RTD intends to contribute to a better understanding about funds available for research and technological development.

    “FundingForum” provides overview and networking on 1st day and specific training on 2nd day
    On the first day, the research community will have access to very useful information about funds by speeches and testimonials of researchers and high-tech companies, which are experienced with specific money resources. We will have the critical mass of public and private funding institutions, foundations and major initiatives present with their booths (at the so called Science Market.). On the second day participants can learn more about how to apply successfully for funds and how to deal with funds in special trainings/workshops.

    Conveying SME means to convey the larger part of economy
    Furthermore, the research intensive Small and Medium sized Enterprises (SMEs) play an important role contributing to strong economic growth and the competitiveness of economic areas. They have also an incredible impact regarding substantial improvements and a better quality of life for the people. Despite all this, public and private funding is declining - a trend that could jeopardize efforts to keep our economic area fit for competing with other players from Asia and the US.

    Target audience

  • professorial & non-professorial faculty of universities
  • PhD students
  • business developers & CEOs of innovative SMEs
  • research managers & administrators

  • The conference
    The first conference will be organised as a two day event to inform the research community and High-Tech and Producing SMEs about “Where to get funds/grants for R&D and how to deal with funds”. On the first day, major funding opportunities will be presented (“Where to get funds/grants for RTD?”). On the second day, workshops will be organised to get more detailed information and special trainings (“How to deal with funds”). The conference will be organised jointly or under the auspicious of many promotion and marketing partners (e.g. European Federation for Biotechnology EFB, Euresearch Zurich, ManuFuture, Young European Biotech Network YEBN). We intend to convince the funding institutions to use this platform to enter in contact with their target groups – the scientist and/or SMEs (National Funding Organisations, EUREKA/Eurostars, COST, EU-FP7, Special SME-Support Programmes, Venture Capital Agencies, Major Private Foundations and Special Thematic Initiatives and Technology Platforms).

    Organisation committee

  • Andrea Degen Iseli, Dr. (CH)
  • Werner Wolf, Dr. (DE)
  • Jacques Viseur, Dr. (BE)
  • Patrick Frei, Dr. (CH)
  • Hartmut Welk, (DE)
  • Yoram Lev-Yehudi, (IL)
  • Anne-Cécile de Giacomoni, (FR)
  • Katrin Reschwamm, (DE)
  • Evangelos Bonoris, (GR)
  • Theodore Pananos, (GR)

  • Kappa Health